COSCIENS Biopharma Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.3M | $16.4M | $6.7M | $10.2M | $6.2M | $24.3M | $7.8M | $14.5M |
| Accounts Receivable | $1.3M | $2.4M | $290.0K | $732.0K | $1.3M | $1.7M | $658.0K | $294.0K |
| Inventory | $1.3M | $2.7M | $4.0M | $229.0K | — | — | — | — |
| Total Current Assets | $11.5M | $24.0M | $11.3M | $55.5M | $70.8M | $27.6M | $10.9M | $16.3M |
| Property, Plant & Equipment | $1.9M | $2.0M | $1.5M | — | — | — | — | — |
| Goodwill | — | — | — | — | $8.1M | $8.8M | $8.1M | $8.2M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $21.4M | $35.1M | $23.7M | $27.8M | $80.1M | $37.0M | $20.0M | $25.0M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $3.6M | $7.2M | $1.3M | $7.0M | $7.8M | $4.7M | $5.7M | $5.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $17.6M | $21.9M | $2.7M | $4.0M | $58.2M | $23.8M | $22.4M | $23.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-20.5M | $-12.1M | $4.4M | $-352.1M | $-334.6M | $-322.7M | $-316.9M | $-309.8M |
| Total Stockholders' Equity | $3.8M | $13.2M | $21.0M | $23.8M | $21.9M | $13.2M | $-2.5M | $1.9M |